[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Kantonsspital Winterthur KSW\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":254},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,39,57,80,114,139,167,199,225],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":4},"100613370","is-treatment-with-fms-tesla-chair-equal-to-physiotherapy-in-first-and-second-degree-urinary-incontinence-100613370",false,"NCT07265700","Is Treatment With FMS Tesla Chair Equal to Physiotherapy in First and Second-degree Urinary Incontinence?","Monocentric Prospective, Randomized, Non-blinded, Active-controlled Trial to Evaluate the Non-inferiority of Functional Magnetic Stimulation (FMS) on the Tesla Chair Compared to Physiotherapy in First or Second-degree Urinary Incontinence","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Urinary incontinence of first or second degree\n* Written informed consent\n* German speaking (Study information and IC available only in German)\n\nExclusion Criteria:\n\n* Pregnancy or desire to become pregnant\n* Urinary incontinence of third degree\n* Third or fourth degree pelvic organ prolapses\n* no noticeable voluntary muscle activity according to Oxford = O\u002F5\n* Genital infections\n* Malignant tumors\n* Severe neurological diseases\n* Cardiac arrhythmia\n* Active internal medical devices e.g. cardiac pacemakers, medication pumps etc.\n* Ferromagnetic implants at or near the site of stimulation\n* Recent surgery at the site of stimulation\n* Thrombosis or thrombophlebitis\n* Epilepsy or suspected epilepsy\n* Acute stages of kidney stones\n* Gastrointestinal and internal disease at the site of stimulation\n* Known or suspected non-compliance, drug or alcohol abuse\n* Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, etc. of the subject\n* Participation in another investigation with an investigational drug or another MD within the 30 days preceding and during the present investigation\n* Previous enrolment into the current investigation\n* Enrolment of the Sponsor or PI, their family members, employees and other dependent persons","FEMALE","18 Years",{"count":19,"type":20},100,"ESTIMATED","INTERVENTIONAL",[23],"NA","100 patients with mild to moderate urinary incontinence will be randomly divided into two groups. One half will receive functional magnetic stimulation with the Tesla Chair for three months, while the other half will be treated with pelvic floor physiotherapy for the same period. After three and six months, a comparison will be made to determine which patient groups experience an improvement in urinary incontinence and how their muscle strength improves.",[26],"Urinary Incontinence","NOT_YET_RECRUITING","2025-11-24",{"date":30,"type":31},"2025-12-05","ACTUAL",{"date":33,"type":20},"2026-01",{"date":35,"type":20},"2028-12",{"name":37,"class":38},"Kantonsspital Winterthur KSW","OTHER",{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":46,"targetDuration":4,"studyType":21,"phases":48,"briefSummary":49,"conditions":50,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":52,"startDateStruct":53,"completionDateStruct":54,"leadSponsor":56,"locationsCount":4},"100613369","impact-of-magnetic-stimulation-on-pain-in-endometriosis-patients-100613369","NCT07265687","Impact of Magnetic Stimulation on Pain in Endometriosis Patients","Pelvic Functional Magnetic Stimulation on Pain in Endometriosis Patients - a Prospective Non Randomised, Non-blinded Single Centre Observational Trial","Inclusion Criteria:\n\n* Patient has been informed about study\n* Age ≥ 18 years\n* Premenopausal\n* histologically or laparoscopically or MRI confirmed endometriosis\n* CPP (cyclical pelvic pain VAS ≥ 5)\n* Pelvic floor hypertonicity\n* Written informed consent\n* sufficient German speaking\n* Current endocrine therapy for \\>= 3 months\n\nExclusion Criteria:\n\n* Contraindications according manufactureres manual Tesla Chair\n* Pregnancy or desire to become pregnant within the next 8 weeks\n* Pelvic organ prolapses\n* Genital infections\n* Menstruation\n* active malignancy, Malignant tumors\n* Severe neurological diseases\n* Cardiac arrhythmia\n* Active internal medical devices e.g. cardiac pacemakers, medication, pumps etc.\n* Ferromagnetic implants at or near the site of stimulation\n* Recent surgery at the site of stimulation\n* Thrombosis or thrombophlebitis\n* Epilepsy or suspected epilepsy\n* Acute stages of kidney stones\n* Gastrointestinal and internal disease at the site of stimulation\n* Known or suspected non-compliance, drug or alcohol abuse\n* Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, etc. of the subject\n* Participation in another investigation with an investigational drug or another MD within the 30 days preceding and during the present investigation\n* Previous enrolment into the current investigation\n* Enrolment of the Sponsor or PI, their family members, employees and other dependent persons\n* No endocrine therapy or use of endocrine therapy for \\\u003C 3 months\n* active inflammatory diseases",{"count":47,"type":20},30,[23],"Many women with endometriosis still experience pain despite surgical and medical treatment. Over-the-counter painkillers are usually helpful in alleviating this pain. But for some patients, these medications eventually stop working. Pain then dominates their daily life. In this study, we are investigating the effects of magnetic stimulation using the \"Tesla chair\" and whether it can alleviate their pain",[51],"Endometriosis",{"date":30,"type":31},{"date":33,"type":20},{"date":55,"type":20},"2028-04",{"name":37,"class":38},{"id":58,"slug":59,"hasResults":11,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":4,"eligibilityCriteria":63,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":64,"targetDuration":4,"studyType":21,"phases":66,"briefSummary":67,"conditions":68,"keywords":4,"overallStatus":70,"whyStopped":4,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},"100526489","comparison-of-laser-treatment-with-clobetasol-therapy-in-patients-with-lichen-sclerosus-100526489","NCT06135402","Comparison of Laser Treatment With Clobetasol Therapy in Patients With Lichen Sclerosus","Monocentric, Prospective, Randomised, Single Blinded, Active-controlled Trial to Prove That the Treatment With Monalisa Glide is Equal to Topic Clobetasol Propionate Maintenance Therapy in Vulvar Lichen Sclerosus","Inclusion Criteria:\n\n* Pre- or postmenopausal\n* 12 weeks of continuous topical clobetasol treatment completed.\n* Written informed consent\n* German speaking (Study information and IC available only in German)\n\nExclusion Criteria:\n\n* Contraindication and limitations for the use of Mona Lisa Glide-Laser as described in the instructions for use\n* Contraindication for the use of topic clobetasol\n* History of vulva laser\n* Immune-suppression\n* Pregnancy or planned pregnancy, breast feeding.\n* Clinically significant concomitant diseases states as severe renal failure, hepatic dysfunction, severe cardiovascular disease, cancer.\n* History of vulvar or pelvic radiation therapy\n* Uncertain vulvar findings, which require a biopsy.\n* Acute vulvitis, especially recurrent genital herpes\n* History of vaginal mesh implantation within 6 months preceding this study\n* Known or suspected non-compliance, drug or alcohol abuse\n* Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, etc. of the subject\n* Participation in another investigation with an investigational drug or another MD within the 30 days preceding and during the present investigation\n* Previous enrolment into the current investigation\n* Enrolment of the PI, his\u002Fher family members, employees and other dependent persons",{"count":65,"type":20},120,[23],"With this trial the investigators look for the effect of Laser maintenance therapy in patients with vulvar lichen sclerosus compared to the maintenance standard treatment clobetasol propionate.",[69],"Lichen Sclerosus","RECRUITING","2025-09-18",{"date":73,"type":31},"2025-09-23",{"date":75,"type":31},"2023-11-10",{"date":77,"type":20},"2027-11-01",{"name":37,"class":38},1,{"id":81,"slug":82,"hasResults":11,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":11,"sex":88,"minAge":89,"maxAge":4,"enrollmentInfo":90,"targetDuration":4,"studyType":21,"phases":91,"briefSummary":92,"conditions":93,"keywords":97,"overallStatus":70,"whyStopped":4,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":112,"locationsCount":113},"100545603","skin-cancer-and-hyperthermia-and-radiotherapy-100545603","NCT06384053","Skin Cancer and Hyperthermia and Radiotherapy","Skin Cancer and Hyperthermia and Radiotherapy - SAHARA a Two-arm, Open-label, Randomized Controlled Phase II Trial","SAHARA","Inclusion Criteria:\n\n* Personally signed and dated written informed consent\n* Histologically confirmed invasive non-melanoma skin cancer (NMSC), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) of any differentiation\n* ≥ T2 (TNM Classification 8th Edition)\n* Tumor thickness up to 2cm (Maximum Depth invasion and\u002For exophytic growth, measured on pathology report or imaging)\n* Local recurrence allowed, if primary treatment longer ago than 6 months (after primary treatment other than radiotherapy (RT))\n* Age ≥ 65 years\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-2, with a life expectancy of more than 6 months\n* Presentation at the Swiss Hyperthermia Network (SHN) tumor conference mandatory\n\nExclusion Criteria:\n\n* Other histology than BCC or SCC\n* T1 tumor and\u002For N+ (according to TNM classification 8th edition)\n* Tumors after resection (R1 or R2 as well as adjuvant indication)\n* Tumor invasion into critical areas\n* Several lesions exceeding the capacity of one treatment\u002Fradiation field (multiple lesions within one treatment field are acceptable)\n* Previous (one month) or concurrent Chemo- or Immunotherapy\n* Patients with connective tissue disorders (e.g. Sclerodermia, Lupus erythematodes)\n* Lesions inside or in proximity (within 3cm) previously irradiated area\n* Medical immunosuppression\n* wIRA-specific exclusion criteria\n\n  * Tattoos in irradiated area\n  * Increased photosensitivity (either due to simultaneous treatment with photosensitivity-enhancing medications or conditions such as porphyria)","ALL","65 Years",{"count":19,"type":20},[23],"The SAHARA trial assesses wether combining ultrahypofractionated accelerated radiotherapy (RT) with hyperthermia is as effective as standard hypofractionated high-dose radiation in treating non-melanoma skin cancer (NMSC).",[94,95,96],"Basal Cell Carcinoma","Squamous Cell Carcinoma Skin","Non-melanoma Skin Cancer",[98,99,100,101,102,103,104],"BCC","SCC skin","w-IRA hyperthermia","radiotherapy for non-melanoma skin cancer","non-melanoma Skin cancer","w-IRA combined with RT","hyperthermia","2025-06-11",{"date":107,"type":31},"2025-06-15",{"date":109,"type":31},"2025-01-01",{"date":111,"type":20},"2028-07-01",{"name":37,"class":38},4,{"id":115,"slug":116,"hasResults":11,"nctId":117,"briefTitle":118,"officialTitle":119,"acronym":120,"eligibilityCriteria":121,"healthyVolunteers":11,"sex":88,"minAge":17,"maxAge":4,"enrollmentInfo":122,"targetDuration":4,"studyType":21,"phases":124,"briefSummary":125,"conditions":126,"keywords":4,"overallStatus":70,"whyStopped":4,"lastUpdateSubmitDate":130,"lastUpdatePostDateStruct":131,"startDateStruct":133,"completionDateStruct":135,"leadSponsor":137,"locationsCount":138},"100470454","stereotactic-multiple-fraction-radiotherapy-for-non-spine-bone-metastases-100470454","NCT05406063","Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases","Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases a Multicentre Prospective, Open Label, Randomised Controlled Phase 3 Non-inferiority Clinical Trial","SMILE","Inclusion Criteria:\n\n* Personally signed and dated written informed consent,\n* Histological diagnosis of malignancy,\n* Histologically or radiologically diagnosed bone metastasis,\n* Age ≥ 18 years\n* Pain or under pain control medication\n\nExclusion Criteria:\n\n* Pregnant or lactating women,\n* Women of childbearing potential or sexually active males not willing to use effective contraception while on treatment and 3 months after the end of treatment,\n* Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, etc.,\n* Prior radiotherapy to the intended treatment site,\n* Lesions \\> 5cm in maximum diameter,\n* Prior treatment with radioactive isotopes within 30 days of randomisation,\n* Spinal column, hands, feet, or head as intended treatment site,- Fracture at the intended treatment site,\n* Surgery required or previous surgery at the intended treatment site\n* Instability of the intended treatment site.",{"count":123,"type":20},162,[23],"To investigate, whether multi-fraction stereotactic body radiation therapy (SBRT) within 3 treatment fractions is non-inferior to the current standard of care of 5 fraction SBRT regarding pain response at 3 months after radiotherapy.",[127,128,129],"Radiation Therapy","Bone Metastases","Pain","2025-05-19",{"date":132,"type":31},"2025-05-22",{"date":134,"type":31},"2022-06-01",{"date":136,"type":20},"2026-05-31",{"name":37,"class":38},2,{"id":140,"slug":141,"hasResults":11,"nctId":142,"briefTitle":143,"officialTitle":144,"acronym":4,"eligibilityCriteria":145,"healthyVolunteers":11,"sex":146,"minAge":17,"maxAge":147,"enrollmentInfo":148,"targetDuration":4,"studyType":21,"phases":150,"briefSummary":151,"conditions":152,"keywords":156,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":159,"lastUpdatePostDateStruct":160,"startDateStruct":162,"completionDateStruct":164,"leadSponsor":166,"locationsCount":4},"100582500","urodynamics-prone-vs-seated-position-100582500","NCT06864117","Urodynamics: Prone Vs. Seated Position","Comparison of Urine Flow Measurements in the Context of Pressure Flow Studies in Men in Supine and Sitting Positions Using a Urinary Condom","Inclusion Criteria:\n\n* Genotype and phenotype XY\n* Age between 18 and 90 years\n* Signed informed consent form\n* Ability to understand and follow the study procedures and understand the consent form\n* possibility ti carry out out the necessary urodynamics as part of the regular clinical examination\n* assessment of neurogenic and\u002For non-neurogenic (idiopathic) bladder dysfunction\n* Spontaneous micturition in a sitting position is possible\n\nExclusion criteria:\n\n* Patients with assistance\u002Fpatients under guardianship\n* Patients with latex allergy or cross-allergy (banana, kiwi, fig, avocado)\n* No spontaneous movement possible in a sitting position\n* Sitting position not possible due to lack of trunk stability\u002Fcirculatory problems\n* Intravesical Botox injection during the last 9 months","MALE","90 Years",{"count":149,"type":20},200,[23],"To demonstrate the feasibility of a pressure-flow study using a urinary condom with drainage tube in the sitting and lying position in everyday clinical practice and the comparability of the measured values with the \"conventional\" pressure-flow studies according to the ICS standard with regard to the diagnosis of outlet obstruction in men.",[153,154,155],"Urodynamic Studies","Urodynamics","Outlet Obstruction",[157,158],"obstruction","urodynamics","2025-03-03",{"date":161,"type":31},"2025-03-07",{"date":163,"type":20},"2025-02-28",{"date":165,"type":20},"2028-02-28",{"name":37,"class":38},{"id":168,"slug":169,"hasResults":11,"nctId":170,"briefTitle":171,"officialTitle":172,"acronym":4,"eligibilityCriteria":173,"healthyVolunteers":11,"sex":88,"minAge":17,"maxAge":4,"enrollmentInfo":174,"targetDuration":4,"studyType":175,"phases":4,"briefSummary":176,"conditions":177,"keywords":185,"overallStatus":70,"whyStopped":4,"lastUpdateSubmitDate":191,"lastUpdatePostDateStruct":192,"startDateStruct":194,"completionDateStruct":196,"leadSponsor":198,"locationsCount":79},"100565526","gastric-emptying-time-in-traumatic-injuries-100565526","NCT06643325","Gastric Emptying Time in Traumatic Injuries","Gastric Point-of-care Sonography with Focus on Gastric Emptying Time in Patients with Traumatic Injuries. a Prospective Observational Study","Inclusion Criteria:\n\n* relevant traumatic injury\n\nExclusion Criteria:\n\n* life-threatening traumatic injury (immediate treatment is necessary)\n* Underage\n* Known pregnancy",{"count":149,"type":20},"OBSERVATIONAL","The investigators plan to do serial sonographic examinations of the gastric antrum (quantity, quality) to estimate the gastric emptying time and dependant factors after traumatic injurys.",[178,179,180,181,182,183,184],"Anesthesia","Gastric Ultrasound","Sonography","Point of Care Ultrasound (POCUS)","Regurgitation","Pulmonary Aspiration During Anesthetic Induction","Trauma Patients",[186,187,188,189,190],"point of care ultrasound","gastric ultrasound","trauma patients","aspiration","anesthesia","2024-10-14",{"date":193,"type":31},"2024-10-16",{"date":195,"type":31},"2023-02-01",{"date":197,"type":20},"2025-09-30",{"name":37,"class":38},{"id":200,"slug":201,"hasResults":11,"nctId":202,"briefTitle":203,"officialTitle":203,"acronym":4,"eligibilityCriteria":204,"healthyVolunteers":11,"sex":88,"minAge":4,"maxAge":4,"enrollmentInfo":205,"targetDuration":207,"studyType":175,"phases":4,"briefSummary":208,"conditions":209,"keywords":211,"overallStatus":70,"whyStopped":4,"lastUpdateSubmitDate":216,"lastUpdatePostDateStruct":217,"startDateStruct":219,"completionDateStruct":221,"leadSponsor":223,"locationsCount":224},"100385557","swiss-sarcoma-network-prediction-model-for-patient-selection-in-sarcoma-care-100385557","NCT04300257","Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care","Inclusion Criteria:\n\n* Malignant and intermediate and selected benign bone or soft tissue tumors, acc. to the WHO coding list of the SSN\n* Female and male subjects of all ages\n\nExclusion Criteria:\n\n* Documented objection of subsequent use of personal health data",{"count":206,"type":20},600,"5 Years","The primary significance of this project is to perform a detailed analysis to assess the diagnostics, treatment and follow-up care, to develop a prediction model for future patient selection regarding various diagnostic and treatment procedures.",[210],"Sarcoma",[212,213,214,215],"Sarcoma, Epithelioid","Sarcoma, Soft Tissue","Sarcoma, Spindle Cell","Sarcoma, Bone","2024-03-19",{"date":218,"type":31},"2024-03-20",{"date":220,"type":31},"2019-10-19",{"date":222,"type":20},"2029-12-31",{"name":37,"class":38},8,{"id":226,"slug":227,"hasResults":11,"nctId":228,"briefTitle":229,"officialTitle":229,"acronym":230,"eligibilityCriteria":231,"healthyVolunteers":11,"sex":88,"minAge":17,"maxAge":4,"enrollmentInfo":232,"targetDuration":234,"studyType":175,"phases":4,"briefSummary":235,"conditions":236,"keywords":239,"overallStatus":70,"whyStopped":4,"lastUpdateSubmitDate":246,"lastUpdatePostDateStruct":247,"startDateStruct":249,"completionDateStruct":251,"leadSponsor":253,"locationsCount":79},"100447867","long-term-cohort-study-of-mesorectal-excision-for-rectal-cancer-100447867","NCT05112016","Long-term Cohort Study of Mesorectal Excision for Rectal Cancer","TME-KSW","Inclusion Criteria:\n\n* Men and Women \\>18 years\n* Patients with rectal cancer\n* Underwent mesorectal excision\n* Agreed to fill in a validated questionnaires before surgery and after stoma reversal\n* Informed consent\n\nExclusion Criteria:\n\n* Age \\\u003C 18\n* No informed consent (no general consent, no consent to use personal data for research purpose)",{"count":233,"type":20},250,"10 Years","The aim of this cohort study is to record, evaluate and compare the surgical, oncological as well as the functional outcome and Quality of life after mesorectal excision for rectal cancer",[237,238],"Rectum","Cancer",[240,241,242,243,244,245],"TME (total mesorectal excision)","Transanal TME","Laparoscopic TME","Robotic TME","Open TME","Quality of life","2021-10-27",{"date":248,"type":31},"2021-11-08",{"date":250,"type":31},"2007-01-01",{"date":252,"type":20},"2028-07-31",{"name":37,"class":38},""]